PVG Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$24.2M |
| 2 |
PhenixFIN
PFX
|
+$9.2M |
| 3 |
GSK
GSK
|
+$6.13M |
| 4 |
Alerian MLP ETF
AMLP
|
+$5.01M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$3.89M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares UltraShort S&P500
SDS
|
+$9.65M |
| 2 |
WSR
Whitestone REIT
WSR
|
+$6M |
| 3 |
Intel
INTC
|
+$4.29M |
| 4 |
Macy's
M
|
+$3.75M |
| 5 |
Bank of America
BAC
|
+$3.61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.93% |
| 2 | Healthcare | 11.71% |
| 3 | Real Estate | 9.56% |
| 4 | Communication Services | 8.07% |
| 5 | Energy | 6.67% |
Similar funds
PVG Asset Management's Q4 2017 Portfolio in Review
As of Q4 2017, PVG Asset Management held 101 positions worth $219M, down 4% from $228M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
PVG Asset Management deployed $17.2M of net new capital in Q4 2017, opening 26 new positions and adding to 17 existing holdings. Its largest new stake was Alerian MLP ETF: 93,581 shares worth $5.05M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 7.3% a quarter earlier, followed by Healthcare and Real Estate.
On the sell side, the largest reduction was ProShares UltraShort S&P500, an estimated $9.65M trimmed.
- PVG Asset Management's largest Q4 2017 buy was Alerian MLP ETF: 93,581 shares worth $5.05M.
- PVG Asset Management added most to CVS Health in Q4 2017, an estimated $24.2M increase.
- PVG Asset Management's biggest Q4 2017 reduction was ProShares UltraShort S&P500, cutting an estimated $9.65M.
- PVG Asset Management fully exited CYS Investments Inc. in Q4 2017, selling an estimated $3.29M.
- PVG Asset Management's ten largest holdings make up 39% of its $219M portfolio in Q4 2017.
- PVG Asset Management opened 26 new positions and closed 23 in Q4 2017.
- PVG Asset Management's portfolio value fell 4% quarter-over-quarter to $219M.
Based on PVG Asset Management's 13F filing for Q4 2017, filed 15 Feb 2018.